Client Login
Be DNA Certain

Biopsy Types

Breast Biopsies

The know error® system for breast biopsies

According to the American Cancer Society, breast cancer is the second most common cancer among women in the United States, second only to cancers of the skin. In fact, it accounts for nearly one in three cancers diagnosed in U.S. women.1

Approximately 1.6 million breast biopsies are performed annually in the U.S. each year,2 about 20% of which will result in a cancer diagnosis.3 Given the complex nature of the biopsy evaluation process executed at this large of a scale, preventing diagnostic mistakes due to Specimen Provenance Complications (SPCs) is crucial to facilitate proper treatment and optimal patient outcomes.

The know error® system for breast biopsies first became available in early 2010 and is now utilized by industry-leading breast centers and radiology practices around the country. Testing is generally performed for any of the following diagnoses:

  • All Malignant cases
  • Atypical Ductal Hyperplasia
  • Ductal Carcinoma In-Situ
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Atypical Lobular Hyperplasia
  • Lobular Carcinoma In-Situ
  • Intraductal Papilloma
  • Paget’s Disease
  • Phyllodes Tumor
1. American Cancer Society. Breast Cancer Facts and Figures 2011-2012. Atlanta: American Cancer Society, Inc.
2. Data provided by Thomson Reuters In-Patient and Out-Patient Views.
3. Silverstein MJ, et al. Image-Detected Breast Cancer: State of the Art Diagnosis and Treatment. Journal of the American College of Surgeons. 2005;201(4):586-597.